{"id":5557,"date":"2015-06-30T14:45:00","date_gmt":"2015-06-30T14:45:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=5557"},"modified":"2021-07-12T07:53:33","modified_gmt":"2021-07-12T07:53:33","slug":"adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/","title":{"rendered":"Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders."},"content":{"rendered":"
\n

Rodolfo Sacco<\/a> 1<\/a><\/sup>, Tomotaka Tanaka<\/a>, Takayuki Yamamoto<\/a>, Giampaolo Bresci<\/a>, Abbi R Saniabadi<\/a>, Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):327-33.<\/p>\n<\/div>\n\n

\n

The authors‘ view is that in patients with UC, there is an evolving scope for therapeutic opportunity based on taking away the sources of inflammatory cytokines, also considering the favorable safety profile of GMA.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/25160857\/<\/a><\/p>\n<\/div>\n\n

\n

<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Rodolfo Sacco 1, Tomotaka Tanaka, Takayuki Yamamoto, Giampaolo Bresci, Abbi R Saniabadi, Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):327-33. The authors‘ view is that in patients with UC, there is an evolving scope for therapeutic opportunity based on taking away the sources of inflammatory cytokines, also considering the favorable safety profile of GMA. https:\/\/pubmed.ncbi.nlm.nih.gov\/25160857\/<\/p>\n","protected":false},"template":"","scientific_tags":[337,50,105,367,107,365,366,306],"class_list":["post-5557","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-apheresis","scientific_tags-colonoscopy","scientific_tags-granulocyte","scientific_tags-loss-of-mucosal-tissue","scientific_tags-monocyte","scientific_tags-mucosal-biopsy","scientific_tags-neutrophil-infiltration","scientific_tags-ulcerative-colitis"],"acf":{"sc_authors":""},"yoast_head":"\nAdacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Rodolfo Sacco 1, Tomotaka Tanaka, Takayuki Yamamoto, Giampaolo Bresci, Abbi R Saniabadi, Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):327-33. The authors‘ view is that in patients with UC, there is an evolving scope for therapeutic opportunity based on taking away the sources of inflammatory cytokines, also considering the favorable safety profile of GMA. https:\/\/pubmed.ncbi.nlm.nih.gov\/25160857\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-12T07:53:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/\",\"name\":\"Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2015-06-30T14:45:00+00:00\",\"dateModified\":\"2021-07-12T07:53:33+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/","og_locale":"de_DE","og_type":"article","og_title":"Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. - Adacyte","og_description":"Rodolfo Sacco 1, Tomotaka Tanaka, Takayuki Yamamoto, Giampaolo Bresci, Abbi R Saniabadi, Expert Rev Gastroenterol Hepatol. 2015 Mar;9(3):327-33. The authors‘ view is that in patients with UC, there is an evolving scope for therapeutic opportunity based on taking away the sources of inflammatory cytokines, also considering the favorable safety profile of GMA. https:\/\/pubmed.ncbi.nlm.nih.gov\/25160857\/","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/","og_site_name":"Adacyte","article_modified_time":"2021-07-12T07:53:33+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/","name":"Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2015-06-30T14:45:00+00:00","dateModified":"2021-07-12T07:53:33+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/adacolumn-leucocytapheresis-for-ulcerative-colitis-clinical-and-endoscopic-features-of-responders-and-unresponders\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/5557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=5557"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=5557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}